TCOV
CDMO

Trust Company of Vermont’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Trust Company of Vermont’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,186
Closed -$6K – 969
2019
Q3 		$6K Buy
1,186
+886
+295% +$5.5K ﹤0.01% 812
2019
Q2 		$2K Buy
+300
New +$1.24K ﹤0.01% 968

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trust Company of Vermont's CDMO Position: Q4 2019 in Review

Trust Company of Vermont sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2019, closing a stake of 1,186 shares — an estimated $6K sold.

Trust Company of Vermont first reported a position in CDMO in Q2 2019 and held it in 2 quarters. The position peaked at $6K in Q3 2019. 114 funds tracked by Wall St. Rank hold CDMO as of Q4 2019.

  • Trust Company of Vermont reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Trust Company of Vermont sold 1,186 Avid Bioservices, Inc. Common Stock shares in Q4 2019, an estimated $6K.
  • Trust Company of Vermont first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Trust Company of Vermont's Avid Bioservices, Inc. Common Stock position peaked at $6K in Q3 2019.
  • 114 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2019.

Based on Trust Company of Vermont's 13F filing for Q4 2019, filed 6 Feb 2020.